Dalpiciclib Isethionate Tablets Combined With Abiraterone Acetate Tablets (I) and Prednisone Tablets (AA-P) Versus Placebo Combined With AA-P in Treatment of High-volume, Metastatic, Hormone-sensitive Prostate Cancer (mHSPC)

NCT06099990 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

660

Enrollment

INDUSTRY

Sponsor class

Conditions

High-volume, Metastatic, Hormone-sensitive Prostate Cancer (mHSPC)

Interventions

DRUG: dalpiciclib isethionate tablets; abiraterone acetate tablets; prednisone tablets
DRUG: placebo; abiraterone acetate tablets; prednisone tablets

Sponsor

Jiangsu HengRui Medicine Co., Ltd.